CFRI Community Newsletter

CFRI Community, CFRI’s newsletter, is printed and distributed twice annually, in the spring and fall of each year. Containing articles on topics of interest to the cystic fibrosis (CF) community, updates on CF research, and announcements of CFRI’s programs, events and services, CFRI Community is mailed to 15,000 subscribers around the globe. An additional 17,000 digital subscribers receive notices when the latest issue has been released.

Issues of CFRI Community, along with the Spanish-language version, CFRI Communidad, are archived and can be accessed through the link below.

View Current CFRI Community Newsletter   View Current CFRI Communidad
Sponsored in 2022 by
Vertex Pharmaceuticals, Genentech, Gilead Sciences, AbbVie, Chiesi USA, and Viatris.